Atlas Trials

A Study to Evaluate the Pharmacokinetics of HSK21542 in Subjects With Renal Impairment

Clinical trial NCT05947097 · UNKNOWN

Trial details

NCT number
NCT05947097
Sponsor
Haisco Pharmaceutical Group Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Renal Impairment
Start date
2023-04-24
Primary completion
2023-07-30
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.